| Trial ID: | L1079 |
| Source ID: | NCT00384384
|
| Associated Drug: |
Oral 18b Glycyrrhetinic Acid Versus Placebo
|
| Title: |
Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease
|
| Interventions: |
DRUG: oral 18B Glycyrrhetinic acid versus placebo
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Insel Gruppe AG, University Hospital Bern
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-08
|
| Completion Date: |
2007-04
|
| Results First Posted: |
|
| Last Update Posted: |
2011-01-13
|
| Locations: |
Department of nephrology and hypertension, University hospital of berne, Berne, 3010, Switzerland
|
| URL: |
https://clinicaltrials.gov/show/NCT00384384
|
